ACOR

Acorda Therapeutics
ACOR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

17 hedge funds and large institutions have $2.13M invested in Acorda Therapeutics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $
Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$112K
2
+$13.2K
3
+$1.36K
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$114
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$13

Top Sellers

1
-$16.1K
2
-$6.88K
3
-$2.54K
4
Wells Fargo
Wells Fargo
California
-$66
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$689K
2
$618K
3
$420K
4
$254K
5
$80.7K
6
$49.4K
7
$15K
8
$3.75K
9
$1.4K
10
$1.36K
11
$674
12
$114
13
$50
14
$39
15
$13
16
$13